HLA Markers in a Community-based Rheumatoid Arthritis Series

References

• Stastny P. Mixed lymphocyte culture typing cells from patients with rheumatoid arthritis. Tissue Antigens 1974; 4: 571–9
   Google Scholar
• Stastny P. Association of the B-cell alloantigen DRw4 with rheumatoid arthritis. N Engi J Med 1978; 298: 869–71
   PubMed Web of Science ®Google Scholar
• Oilier W, Thomson W. Population genetics of rheumatoid arthritis. Rheum Dis Clin North Am 1992; 18: 741–59
   PubMed Web of Science ®Google Scholar
• Hakala M, Tiilikainen A, Hameenkorpi R, et al. Rheumatoid arthritis with pleural effusion includes a subgroup with autoimmune features and HLA-B8, Dw3 association. Scand J Rheumatol 1986; 15: 290–6
   PubMed Web of Science ®Google Scholar
• De Jongh B M, van Romunde L KJ, Valkenberge H A, de Lange G G, van Rood J J. Epidemiological study of HLA and Gm in rheumatoid arthritis and related syndromes in an open Dutch population. Ann Rheum Dis 1984; 43: 613–9
   PubMed Web of Science ®Google Scholar
• Thomson W, Pepper L, Payton A, et al. Absence of an association between HLA-DRB1*04 and rheumatoid arthritis in newly diagnosed cases from the community. Ann Rheum Dis 1993; 52: 539–41
   PubMed Web of Science ®Google Scholar
• Jaraquemada D, Oilier W, Awad J, et al. HLA and rheumatoid arthritis: a combined analysis of 440 British patients. Ann Rheum Dis 1986; 45: 627–36
   PubMedGoogle Scholar
• Westedt M L, Breedveld F C, Th Schreuder G M, ĎAmaro J, Cats A, De Vries R RP. Immunogenetic heterogeneity of rheumatoid arthritis. Ann Rheum Dis 1986; 45: 534–8
   PubMedGoogle Scholar
• Cunningham T J, Tait B D, Mathews J D, Muirden K D. Clinical rheumatoid vasculitis associated with the B8 DR3 phenotype. Rheumatol Int 1982; 2: 137–9
   PubMedGoogle Scholar
• Oilier W, Venables P JW, Mumford P A, et al. HLA antigen associations with extra-articular rheumatoid arthritis. Tissue Antigens 1984; 24: 279–91
   PubMedGoogle Scholar
• Boki K A, Drosos A A, Tzioufas A G, Lanchbury J S, Panayi G S, Moutsopoulos H M. Examination of HLA-DR4 as a severity marker for rheumatoid arthritis in Greek patients. Ann Rheum Dis 1993; 52: 517–9
   PubMed Web of Science ®Google Scholar
• Möttönen T T. Prediction of erosiveness and rate of development of new erosions in early rheumatoid arthritis. Ann Rheum Dis 1988; 47: 648–53
   PubMed Web of Science ®Google Scholar
• Paimela L, Leirisalo-Repo M, Koskimies S. The prognostic value of HLA DR4 and B27 antigens in early rheumatoid arthritis. Scand J Rheumatol 1993; 22: 220–4
   PubMed Web of Science ®Google Scholar
• Gregersen P K, Silver J, Winchester R J. The shared epitope hypothesis. An approach to understanding the molecular genetics of susceptibility to rheumatoid arthritis. Arthritis Rheum 1987; 30: 1205–13
   PubMed Web of Science ®Google Scholar
• Bodmer J G, Marsh S GE, Albert E D, et al. Nomenclature for factors of the HLA system, 1995. Tissue Antigens 1995; 46: 1–18
   PubMedGoogle Scholar
• Arnett F C. Histocompatibility typing in the rheumatic diseases. Diagnostic and prognostic implications. Rheum Dis Clin North Am 1994; 20: 371–90
   PubMedGoogle Scholar
• Weyand C M, Hicok K C, Conn D L, Goronzy J J. The influence of HLA-DRB1 genes on disease severity in rheumatoid arthritis. Ann Intern Med 1992; 117: 801–6
   PubMed Web of Science ®Google Scholar
• Symmons D PM, Oilier W ER, Brennan P, Silman A J. Should patients with recent onset rheumatoid arthritis be offered genetic screening?. Ann Rheum Dis 1996; 55: 407–10
   PubMedGoogle Scholar
• Arnett F C, Edworthy S M, Bloch D A, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988; 31: 315–24
   PubMed Web of Science ®Google Scholar
• Hakala M, Pöllänen R, Nieminen P. The ARA 1987 revised criteria select patients with clinical rheumatoid arthritis from a population based cohort of subjects with chronic rheumatic diseases registered for drug reimbursement. J Rheumatol 1993; 20: 1674–8
   PubMed Web of Science ®Google Scholar
• Keitel W, Hoffmann H, Weber G, Krieger U. Ermittlung der prozentualen Funktionsminderung der Gelenke durch einen Bewegungsfunktionstest in der Rheumatologie. Dtsch Gesundh-Wes 1971; 26: 1901–3
   PubMedGoogle Scholar
• Hakala M, Nieminen P. Functional status assessment of physical impairment in a community based population with rheumatoid arthritis: severely incapacitated patients are rare. J Rheumatol 1996; 23: 617–23
   PubMed Web of Science ®Google Scholar
• Wolfe F, Kleinheksel S M, Cathey M A, Hawley D J, Spitz P W, Fries J F. The clinical value of the Standford Health Assessment Questionnaire Functional Disability Index in patients with rheumatoid arthritis. J Rheumatol 1988; 15: 1480–8
   PubMed Web of Science ®Google Scholar
• Larsen A, Dale K, Eek M. Radiographic evaluation of rheumatoid arthritis and related conditions by standard reference films. Acta Radiol Diagn (Stockh) 1977; 18: 481–91
   PubMed Web of Science ®Google Scholar
• Moore D. Preparation and analysis of DNA. Current Protocols in Molecular Biology, F Ausubel, R Brent, R Kingston, D Moore, J Smith, J Seidman, K Struhl. Wiley, New York 1994; Vol. 1.
   Google Scholar
• Hietarinta M, Ilonen J, Lassila O, Hietaharju A. Association of HLA antigens with anti-Scl-70-antibodies and clinical manifestations of systemic sclerosis (scleroderma). Br J Rheumatol 1994; 33: 323–6
   PubMedGoogle Scholar
• Wordsworth P, Pile K D, Buckeiy J D, et al. HLA heterozygosity contributes to susceptibility to rheumatoid arthritis. Am J Hum Genet 1992; 51: 585–91
   PubMed Web of Science ®Google Scholar
• Suarez-Almazor M E, Tao S, Moustarah F, Russell A S, Maksymowych W. HLA-DR1, DR4, and DRB1 disease related subtypes in rheumatoid arthritis. Association with susceptibility but not with severity in a city wide community based study. J Rheumatol 1995; 22: 2027–33
   PubMedGoogle Scholar
• Ropes M W, Bennett G A, Cobb S, Jacox R, Jessar R A. 1958 revision of diagnostic criteria for rheumatoid arthritis. Bull Rheum Dis 1958; 9: 175–6
   PubMedGoogle Scholar
• Emery P, Salmon M, Bradley H, et al. Genetically determined factors as predictors of radiological change with early symmetrical arthritis. BMJ 1992; 305: 1387–9
   PubMed Web of Science ®Google Scholar
• Eberhardt K, Fex E, Johnson U, Wollhelm F A. Associations of HLA-DRB and -DQB genes with two and five year outcome in rheumatoid arthritis. Ann Rheum Dis 1996; 55: 34–9
   PubMed Web of Science ®Google Scholar
• MacGregor A, Oilier W, Thomson W, Jawaheer D, Silman S. HLA-DRB10401/0404 genotype and rheumatoid arthritis: increased association in men, young age at onset, and disease severity. J Rheumatol 1995; 22: 1032–6
   PubMed Web of Science ®Google Scholar
• Hakala M, Ilonen J, Tiilikainen A. HLA antigens Dw4 and Dw14 in rheumatoid arthritis. Ann Rheum Dis 1987; 46: 492–3
   PubMedGoogle Scholar
• Panayi G S, Wooley P, Batchelor J R. Genetic basis of rheumatoid disease: HLA antigens, disease manifestations and toxic reactions to drugs. BMJ 1978; 2: 1326–8
   PubMed Web of Science ®Google Scholar
• Teller K, Budhai L, Zhang M, Haramati N, Keiser H D, Davidson A. HLA-DRB1 and DQB typing of Hispanic American patients with rheumatoid arthritis: the ‘shared epitope’ hypothesis may not apply. J Rheumatol 1996; 23: 1363–8
   PubMedGoogle Scholar